Login / Signup

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people.

Julia Hippisley-CoxPui San TanCarol Coupland
Published in: Heart (British Cardiac Society) (2020)
Keyphrases
  • angiotensin converting enzyme
  • angiotensin ii
  • coronavirus disease
  • sars cov
  • early onset
  • binding protein
  • drug induced